一种电压敏感超声增强剂用于大鼠模型心肌灌注成像
本研究在大鼠模型中评估电压敏感超声增强剂(UEA)用于心肌灌注成像的活体临床可行性。四种UEA注入Sprague-Dawley大鼠,定量收缩期和舒张期左心室腔、室间隔壁和后壁的亮度。配方IV(嵌套于带负电荷磷脂双层的相变剂)使室间隔壁组织与腔比值在收缩期和舒张期均增加6 dB,后壁增加5 dB,而左心室腔保持基线水平。
要点
- 配方IV使室间隔壁组织与腔比值在收缩期和舒张期均增加6 dB,后壁增加5 dB。
- 配方IV使左心室腔亮度保持基线水平,提升心肌相对左心室腔的信号。
- 该电压敏感UEA在大鼠模型中显示出作为心肌灌注超声增强剂的潜力。
关键影像表现/征象
- 配方IV为嵌套于带负电荷磷脂双层的相变剂。
- 配方IV使室间隔壁组织与腔比值在收缩期和舒张期均增加6 dB。
- 配方IV使后壁组织与腔比值增加5 dB。
- 配方IV使左心室腔亮度保持基线水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Echocardiographers with specialized expertise sometimes perform myocardial perfusion imaging using U.S. Food and Drug Administration-approved microbubbles in an off-label capacity, correlating microbubble replenishment in the near field with blood flow through the myocardium. This study reports the in vivo clinical feasibility of a voltage-sensitive ultrasound enhancing agent (UEA) for myocardial perfusion imaging. Four UEAs were injected into Sprague-Dawley rats while ultrasound images were collected to quantify brightness in the left ventricular (LV) cavity, septal wall, and posterior wall in systole and diastole. Formulation IV, a phase change agent nested within a negatively charged phospholipid bilayer, increased the tissue-to-cavity ratio in both systole and diastole in the septal wall, 6 dB, and in the posterior wall, 5 dB, while leaving the LV cavity at baseline. This outcome improves the signal of the myocardium relative to the LV cavity and shows promise as a myocardial perfusion UEA.
引用
- Cimorelli M, Flynn MA, Angel B, et al. A Voltage-Sensitive Ultrasound Enhancing Agent for Myocardial Perfusion Imaging in a Rat Model. Ultrasound Med Biol. 2020. PMID: 32593498. doi:10.1016/j.ultrasmedbio.2020.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。